517 related articles for article (PubMed ID: 18262098)
1. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
Park C; Papiez L; Zhang S; Story M; Timmerman RD
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
[TBL] [Abstract][Full Text] [Related]
2. A comparative analysis of radiobiological models for cell surviving fractions at high doses.
Andisheh B; Edgren M; Belkić D; Mavroidis P; Brahme A; Lind BK
Technol Cancer Res Treat; 2013 Apr; 12(2):183-92. PubMed ID: 23098282
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
Chan MKH; Chiang CL
Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
[TBL] [Abstract][Full Text] [Related]
4. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.
Kirkpatrick JP; Meyer JJ; Marks LB
Semin Radiat Oncol; 2008 Oct; 18(4):240-3. PubMed ID: 18725110
[TBL] [Abstract][Full Text] [Related]
5. SU-E-T-457: Multi-Mode Model - A Consistent Approach for Conventionally Fractionated Radiotherapy and Stereotactic Body Radiotherapy.
Ma C
Med Phys; 2012 Jun; 39(6Part17):3810. PubMed ID: 28517486
[TBL] [Abstract][Full Text] [Related]
6. NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
Wennberg BM; Baumann P; Gagliardi G; Nyman J; Drugge N; Hoyer M; Traberg A; Nilsson K; Morhed E; Ekberg L; Wittgren L; Lund JÅ; Levin N; Sederholm C; Lewensohn R; Lax I
Acta Oncol; 2011 May; 50(4):518-27. PubMed ID: 21198416
[TBL] [Abstract][Full Text] [Related]
7. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
[TBL] [Abstract][Full Text] [Related]
8. The impact of fractionation in SBRT: analysis with the linear quadratic model and the universal survival curve model.
Wennberg B; Lax I
Acta Oncol; 2013 Jun; 52(5):902-9. PubMed ID: 23327339
[TBL] [Abstract][Full Text] [Related]
9. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
[TBL] [Abstract][Full Text] [Related]
10. Alpha/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy.
Scheenstra AE; Rossi MM; Belderbos JS; Damen EM; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):224-8. PubMed ID: 24331668
[TBL] [Abstract][Full Text] [Related]
11. Fitting techniques of cell survival curves in high-dose region for use in stereotactic body radiation therapy.
McKenna FW; Ahmad S
Phys Med Biol; 2009 Mar; 54(6):1593-608. PubMed ID: 19229092
[TBL] [Abstract][Full Text] [Related]
12. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.
Woody NM; Videtic GM; Stephans KL; Djemil T; Kim Y; Xia P
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):427-34. PubMed ID: 22197087
[TBL] [Abstract][Full Text] [Related]
13. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.
Iwata H; Shibamoto Y; Murata R; Tomita N; Ayakawa S; Ogino H; Ito M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):482-8. PubMed ID: 19735872
[TBL] [Abstract][Full Text] [Related]
14. Tumor Control Probability Analysis for Single-Fraction Carbon-Ion Radiation Therapy of Early-Stage Non-small Cell Lung Cancer.
Paz AE; Yamamoto N; Sakama M; Matsufuji N; Kanai T
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1551-1559. PubMed ID: 30076985
[TBL] [Abstract][Full Text] [Related]
15. Fitting the linear-quadratic model to detailed data sets for different dose ranges.
Garcia LM; Leblanc J; Wilkins D; Raaphorst GP
Phys Med Biol; 2006 Jun; 51(11):2813-23. PubMed ID: 16723768
[TBL] [Abstract][Full Text] [Related]
16. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066
[TBL] [Abstract][Full Text] [Related]
17. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy: in regard to Parks et al. (Int J Radiat Oncol Biol Phys 2008;72:1620-1621).
Tomé WA
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286. PubMed ID: 19251106
[No Abstract] [Full Text] [Related]
18. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
19. Predicting the clonogenic survival of A549 cells after modulated x-ray irradiation using the linear quadratic model.
Bromley R; Oliver L; Davey R; Harvie R; Baldock C
Phys Med Biol; 2009 Jan; 54(2):187-206. PubMed ID: 19088388
[TBL] [Abstract][Full Text] [Related]
20. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
